Physician's Main :: Efficacy :: Improved Bone Quality

Building bone health harmoniously

Shown to promote good bone quality and reduce bone loss

Multiple studies demonstrate calcitonin-salmon efficacy in maintaining
and improving bone quality and prevention
of bone loss

  • Bone quality
    • Shown to preserve or improve trabecular microarchitecture§6
  • Bone loss
    • Shown to reduce the risk of bone loss by 81% vs placebo‡4
    • Shown to rapidly decrease plasma markers of bone resorption as early as 1 month of use5

 

 

HOME | PRESCRIBING INFORMATION | CORPORATE | PRIVACY POLICY | LEGAL NOTICES


IMPORTANT SAFETY INFORMATION
Indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass relative to healthy premenopausal women. Recommended in conjunction with adequate calcium and vitamin D intake. The most common adverse events were rhinitis, other nasal symptoms, back pain, arthralgia, epistaxis, and headache. Periodic nasal examinations are recommended; if nasal ulceration occurs, discontinue treatment until healed. Because calcitonin-salmon is a protein, the possibility of systemic allergic reaction exists. Please refer to full prescribing information.